AC
DNA icon

Allstate Corporation’s Ginkgo Bioworks DNA Stock Holding History

Allstate Corporation’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$698K Buy
70,455
+24,494
+53% +$205K 0.01% 893
2026
Q1 		$282K Buy
+45,961
New +$382K ﹤0.01% 1085

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Allstate Corporation's DNA Position: Q2 2026 in Review

Allstate Corporation increased its Ginkgo Bioworks (DNA) stake by 53% in Q2 2026, buying an estimated $205K and bringing the position to 70,455 shares worth $698K. The position accounts for 0.01% of the portfolio, ranked #893.

Allstate Corporation first reported a position in DNA in Q1 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Allstate Corporation held 70,455 shares of Ginkgo Bioworks worth $698K as of Q2 2026.
  • Allstate Corporation bought 24,494 Ginkgo Bioworks shares in Q2 2026, an estimated $205K.
  • Ginkgo Bioworks made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #893 holding.
  • Allstate Corporation first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.